Schedule 13G ownership disclosure

SCICLONE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 80862K104

Event date: 2016-09-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,562,923
Percent of class
5.1300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-16-008209
Form type
SC 13G
Filer
Man Group plc
CIK
CIK 1637460
Filed
Sep 22, 2016
Reporting period
Sep 16, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub